Kun for helsepersonell

Viktig sikkerhets-og forskrivningsinformasjon: Breyanzi® (lisocabtagene maraleucel)

image

How can we improve outcomes for patients with R/R LBCL?

Interview: 3 minutes

Listen to Prof. Sirpa Leppä, Chair of the Nordic Lymphoma Group, as she discusses key focus areas for improving outcomes across different patient groups with aggressive B-cell lymphomas.

 

Related videos

Biomarkers in LBCL
From Clinical Study To Clinical Practice with CAR-T

News

Learn about current topics in hematology, such as new research data, news from events, congresses and more.

Education

Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.

 

HE-SE-2400026 Feb 2025 video/2009-NO-2500020 Dec 2025